Furthermore, tumor cells can enhance PD‐L1 expression by activating signaling pathways such as JAK/STAT, PI3K/AKT, and MAPK in response to inflammatory factors like IFN‐γ or internal genetic alterations within the TME.229. This evidence concerns the gene AKT1 and neoplasm.